Condition

Chemobrain

ClinicalTrials.gov condition label

Clinical trials3

Recruiting0

Common interventions8

Lead sponsors shown3

Clinical trials

3 shown

Impact of Supplementation With Synbiotics and Prebiotics on Cognitive Decline Associated With Neoadjuvant Chemotherapy in First-line Patients With Breast CancerNCT07465497 · 2026-02-27

ENROLLING_BY_INVITATION

Cognitive Impairment in Treated Breast Cancer Survivors: Possible ApproachesNCT06662474 · 2024-11-01

NOT_YET_RECRUITING

Nicotinic Treatment of Post-Chemotherapy Subjective Cognitive Impairment: A Pilot StudyNCT02312934 · 2015-08-01

COMPLETED

Common interventions

1. cognitive stimulationOTHER12. psychoeducation and cognitive stimulationOTHER13. no interventionOTHER1Placebo Transdermal PatchOTHER1PrebioticDIETARY_SUPPLEMENT1Synbiotics + Vitamin DDIETARY_SUPPLEMENT1Synbiotics BlendDIETARY_SUPPLEMENT1Transdermal nicotineDRUG1

Leading sponsors

Grigore T. Popa University of Medicine and Pharmacy1Instituto Jalisciense de Cancerologia1Vanderbilt University Medical Center1

Trial status mix

COMPLETED1

ENROLLING_BY_INVITATION1

NOT_YET_RECRUITING1

Phase mix

NA2

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.